Regulatory Approval

Chinese medical giant Winner Medical breaks ground in Vietnam, a move highlighting the global push for resilient supply chains beyond China.

Digital asset giant BIT gains crucial regulatory approval in the British Virgin Islands, a major step in building a compliant global network for pro investors.

Two specialist investors are merging to create the world's largest dedicated healthcare fund, aiming to reshape global health innovation from West to East.

A coalition of utilities seeks to suspend competitive bidding on grid projects, a move critics say is a power grab that will cost consumers billions.

Chinese FinTech giant Lianlian lands a key license in Dubai, building an AI-driven payment network to power the booming East-West trade corridor.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

Sponsor of Truth Social Funds drops '33 Act plans, embracing the '40 Act to build more innovative, rules-based products for its investor base.

A new state security certification for PARiConnect is set to streamline access to vital psychological and educational assessments for Texas students.

Dubai-based robotics firm Micropolis AI is under scrutiny after a delayed annual report triggered a warning from the NYSE American exchange.

A new partnership embeds advanced cybersecurity directly into electric meters, creating a new line of defense against attacks on the nation's power grid.

A new Silicon Valley facility will use advanced robots to turn mountains of paper into the high-quality data that artificial intelligence desperately needs.

Three ZenaTech AI drone platforms have entered the final cybersecurity phase for Blue UAS certification, a critical step to accessing the U.S. defense market.

Chris Brown's appointment to the Fast Company Executive Board signals a shift toward practical, compliant AI solutions in high-stakes industries.

Alchemy Pay's new blockchain seeks to unite EU and Hong Kong rules, promising to slash costs for African cross-border trade with a compliant stablecoin.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

Out of 48,000 vulnerabilities, only 58 were critical supply chain threats. A new report reveals how AI is changing the game for cyber risk.

With a $15M boost, a tech veteran's personal health crisis fuels a mission to revolutionize blood pressure monitoring for millions worldwide.

As FINRA scraps the Pattern Day Trader rule, PropShop's move into equities with Sterling's real-time risk platform signals a new era for prop firms.

SERB Pharma's acquisition of Idefirix® rights offers new hope to thousands of highly sensitized patients previously unable to receive a kidney transplant.

Mineralys Therapeutics' lorundrostat shows promise for millions with uncontrolled blood pressure and kidney disease, targeting a key hormonal driver.